Epstein-Barr virus infections following OKT3 treatment.
Junker
A K
AK
Chan
K W
KW
Lirenman
D S
DS
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D006566:Herpesviridae Infections / Q000139:chemically induced* / Q000209:etiology; D004854:Herpesvirus 4, Human; D006801:Humans; D016031:Liver Transplantation; D016853:Muromonab-CD3; D014184:Transplantation, Homologous / Q000009:adverse effects
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3